花旗：将腾讯音乐(01698.HK)目标价格从17美元上调至23美元。 ...

Core Viewpoint - The Hang Seng Tech Index experienced a significant decline, dropping nearly 2% during trading, with Alibaba Health seeing a drop of over 7% [1] Group 1 - The Hang Seng Tech Index's intraday performance indicates a bearish trend in the technology sector [1] - Alibaba Health's stock performance reflects broader market concerns, as it fell more than 7%, suggesting potential investor apprehension [1]

Core Viewpoint - The report from CICC maintains the profit forecast for Dekang Agriculture (02419) for 2025/26, with the current stock price corresponding to P/E ratios of 11.5 and 6.7 for those years. The target price is raised by 68% to HKD 111, indicating a potential upside of 28% from the current price, supported by the company's continued growth and improved trading liquidity [1] Group 1 - The company adopts a "company + farmer" light asset development model, with the second farm's sow breeding model achieving the lowest costs within the system. The current operational model distribution is 20% self-operated, 60% first farm, and 20% second farm, with the average annual income for contracted farmers reaching RMB 770,000, a historical high for the company [2] - The second farm model has lower breeding costs compared to the first farm and self-operated models, enhancing operational efficiency and farmer engagement [2] Group 2 - The company continues to reduce costs, maintaining its position as an industry leader. The monthly total cost is reported to be below RMB 12.5 per kilogram, attributed to a focused breeding strategy in the Southwest region, technological empowerment, and efficient management practices [3] - The company expects to achieve a pig output of 11 million and 15 million heads in 2025 and 2026, respectively, with long-term potential exceeding 30 million heads [3] Group 3 - Liquidity has improved significantly, with an average turnover rate of 1.9% since the release of the 2024 annual report, and average daily trading volume increasing to RMB 140 million from RMB 3.69 million year-on-year. The proportion of Hong Kong Stock Connect has also risen [4] - The valuation of the company is expected to increase, with a calculated average market value of RMB 2,528 per head, indicating a 22% potential increase compared to industry leaders [4]

Core Viewpoint - CICC maintains its profit forecast for Hutchison China MediTech (00013) at $360 million for 2025 and $100 million for 2026, with a target price of HKD 30, indicating a 20.5% upside from the current stock price [1] Group 1: Drug Approval and Market Potential - The recently approved indication for Savolitinib is the largest for the drug to date [2] - Approximately 10-25% of non-small cell lung cancer (NSCLC) patients in the US and Europe have EGFR mutations, while the rate is as high as 30-40% in Asian patients [2] - MET amplification is a major mechanism of acquired resistance in EGFR-mutant NSCLC patients, with 15-50% of patients showing MET abnormalities after third-generation EGFR TKI treatment [2] Group 2: Clinical Trial Results - The approval is based on the SACHI Phase III study, which showed significant progression-free survival (PFS) benefits compared to platinum-based chemotherapy [3] - In the SACHI intent-to-treat population, the median PFS for the Savolitinib + Osimertinib combination was 8.2 months and 7.2 months, compared to 4.5 months and 4.2 months for the chemotherapy group, reducing the risk of disease progression by 66% and 60% respectively [3] Group 3: Ongoing Clinical Trials and Regulatory Progress - The SAFFRON Phase III clinical trial is ongoing, focusing on regulatory registration progress overseas [4] - The combination therapy received Fast Track designation from the FDA in 2023, with AstraZeneca conducting the SAFFRON trial to evaluate its effectiveness against platinum-based doublet chemotherapy in MET-overexpressing NSCLC [4] - Attention is recommended on the data readout from SAFFRON in 2026 and the overseas application status [4]

Group 1: Regulatory Changes - Beijing's housing authority has proposed a notification to regulate individuals renting out 10 or more housing units, requiring them to register as market entities and file with housing management departments [1] Group 2: Real Estate Transactions - China State Construction Engineering Corporation acquired a land parcel in Beijing's Yanqing District for a base price of 560 million yuan, covering an area of approximately 22,300 square meters with a planned construction area of about 36,100 square meters [2] - Yuexiu Property reported a contract sales amount of approximately 10.8 billion yuan in June, representing a year-on-year decline of about 29.4%, with a sales area of approximately 293,000 square meters, down about 39.7% year-on-year [3] - Poly Developments disclosed a contract signing amount of 29.011 billion yuan in June, with a signed area of 1.5233 million square meters, reflecting a year-on-year decrease of 30.95% [5] Group 3: Financing Activities - Vanke A announced an application for a loan of up to 6.249 billion yuan from its largest shareholder, Shenzhen Metro Group, to repay bond principal and interest, with a loan term of no more than three years [4]

菲律宾央行：将通过确保货币政策有利于可持续经济增长和就业来维护物价稳定。 ...

Group 1 - The Hang Seng Index opened down 0.7%, with the Hang Seng Tech Index falling 0.75%. Alibaba Health dropped nearly 5%, and AIA Group fell nearly 2% [1] - According to Zhongtai International, the technical bull market pattern for Hong Kong stocks is clear in the first half of the year, with expectations for continued strength in the market under supportive policies and improved US dollar liquidity in the second half of 2025 [1] - Earnings per share for the Hang Seng Index are projected to grow by 8.5% and 8.3% in 2025 and 2026, respectively [1] Group 2 - CITIC Securities anticipates that the ongoing reform of the Hong Kong listing system will enhance the asset quality and liquidity of the market, with southbound capital likely to continue flowing into Hong Kong stocks [2] - The market is expected to show a trend of "oscillation upwards + structural differentiation" in the second half of the year, driven by macro policies focusing on high-quality development, technological innovation, and domestic demand [2] - Annual net inflow of southbound funds is expected to exceed 1 trillion yuan, continuously improving liquidity in the Hong Kong stock market [2]

Group 1 - The Hang Seng Index opened down by 0.7% and the Hang Seng Tech Index opened down by 0.75% [1] - Xiaopeng Motors (09868.HK) opened down nearly 2% following the launch of its first L3-level AI vehicle, the Xiaopeng G7 [1]

恒指低开0.70%，报23900.69点；恒生科技指数跌0.75%。阿里健康跌4.9%，小鹏汽车跌近2%，腾讯、 美团、网易、小米等跌超1%。 ...

Core Viewpoint - Jin Jing New Energy's latest financial report indicates significant progress in its transformation towards the green energy sector, showcasing a remarkable increase in revenue and a substantial reduction in losses [1][3][14]. Financial Performance - For the fiscal year 2025, Jin Jing New Energy reported revenue of approximately HKD 870 million, a year-on-year increase of 92.3%, while the loss attributable to shareholders was HKD 15.74 million, a significant reduction of 80% compared to the previous year's loss of HKD 78.86 million [1][4]. - The adjusted EBITDA for the fiscal year 2025 was HKD 44.76 million, a substantial improvement from a loss of HKD 40.06 million in 2024, indicating a turnaround in profitability [5][6]. Business Transformation - The company has successfully transitioned from traditional construction to focusing on green infrastructure, particularly in the recycling and utilization of power batteries, since its listing in 2018 [3][14]. - The revenue from reverse supply chain management and environmental services surged by 204.21% to HKD 696.19 million in 2025, accounting for nearly 80% of total revenue, highlighting the effectiveness of the company's strategic shift [4][3]. Market Trends - The global market for retired lithium batteries is expected to peak soon, driven by supportive policies from major countries, including China's new regulations on battery recycling [7][8]. - The anticipated retirement of approximately 300 GWh of batteries in China by 2030, along with similar trends in Europe and North America, presents a significant growth opportunity for Jin Jing New Energy [8][9]. Catalysts for Future Growth - The company is set to launch Hong Kong's first battery processing facility, which is expected to meet the battery processing needs outlined in Hong Kong's 2035 plan, with operations commencing in 2026 [9][10]. - Existing contracts with major clients, including leading electric vehicle manufacturers, are expected to contribute significantly to future revenue growth, with estimated disposal values exceeding HKD 30 billion [11][10]. - The establishment of a global lithium battery recycling network platform, in collaboration with other industry leaders, is anticipated to enhance the company's operational capabilities and market presence [12][13]. Market Recognition - The capital market has recognized the company's successful transformation, reflected in its stock price increase since 2022 and its inclusion in the MSCI index, indicating growing institutional interest [14].